Open AccessAnti-Neoplastic Drug Exposure in Pregnancy and Fetal Haemorrhage: A Rare Teratogenicity
Author(s) -
Anupama Hari,
Bushra Shereen,
J Sreeja Shraddha
Publication year - 2022
Publication title -
scholars international journal of obstetrics and gynecology
Language(s) - English
Resource type - Journals
eISSN - 2617-3492
pISSN - 2616-8235
DOI - 10.36348/sijog.2022.v05i03.011
Subject(s) - ecchymosis , medicine , pregnancy , fetus , drug , obstetrics , products of conception , gynecology , gestation , surgery , pharmacology , genetics , biology
Anti-neoplastic drugs are known to have teratogenic effects on the fetus. In this case report we are presenting a case of a patient who got operated for breast carcinoma, conceived while on chemotherapy and underwent termination of pregnancy in the second trimester. Fetal haemorrhage and ecchymosis lead to further evaluation of the case, which revealed fetal thrombocytopenia, a rare teratogenic effect of the anti-neoplastic drugs.